Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options
Authors:
- 1 September 2018
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Oncology
- Vol. 19 (10) , 49
Abstract
Peritoneal metastases (PM) are common in advanced-stage colorectal cancer (CRC) patients representing the second most common metastatic site of CRC. In the past, this clinical situation was treated with palliative intent. The introduction of new chemotherapeutic and targeted biologic agents has improved the prognosis of patients with metastatic colorectal cancer. However, the inclusion of treatment options such as cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) as inherent components of a multidisciplinary treatment was evolving for the management of these patients. Notably, the surgical approach of CRS/HIPEC has been effective offering a prolonged survival with curative intent in patients with colorectal PM. This article reviews and highlights the recent evidence of CRS and HIPEC as well as current research going on in this form of locoregional treatment in the setting of peritoneal metastases of colorectal cancer.Keywords
This publication has 118 references indexed in Scilit:
- Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch ProtocolAnnals of Surgical Oncology, 2013
- Should Patients With Peritoneal Carcinomatosis of Colorectal Origin With Synchronous Liver Metastases Be Treated With a Curative Intent? A Case-Control StudyAnnals of Surgery, 2013
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety AspectsAnnals of Surgical Oncology, 2013
- Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative ChemotherapyThe Scientific World Journal, 2013
- Definition of Patients Presenting a High Risk of Developing Peritoneal Carcinomatosis After Curative Surgery for Colorectal Cancer: A Systematic ReviewAnnals of Surgical Oncology, 2012
- Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal CarcinomatosisAnnals of Surgery, 2011
- Evaluation of Best Supportive Care and Systemic Chemotherapy as Treatment Stratified according to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for Peritoneal Carcinomatosis of Colorectal OriginBMC Cancer, 2010
- Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French StudyJournal of Clinical Oncology, 2010
- Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal OriginJournal of Clinical Oncology, 2009
- Results of Systematic Second-Look Surgery in Patients at High Risk of Developing Colorectal Peritoneal CarcinomatosisAnnals of Surgery, 2008